MX2014001767A - Metodos para reducir sintomas o condiciones causados por estres. - Google Patents
Metodos para reducir sintomas o condiciones causados por estres.Info
- Publication number
- MX2014001767A MX2014001767A MX2014001767A MX2014001767A MX2014001767A MX 2014001767 A MX2014001767 A MX 2014001767A MX 2014001767 A MX2014001767 A MX 2014001767A MX 2014001767 A MX2014001767 A MX 2014001767A MX 2014001767 A MX2014001767 A MX 2014001767A
- Authority
- MX
- Mexico
- Prior art keywords
- stress
- conditions caused
- methods
- ameliorating symptoms
- fatty acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Pain & Pain Management (AREA)
- Mycology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Birds (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Otolaryngology (AREA)
- Anesthesiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
Abstract
La invención proporciona métodos para usar alcanolamidas de ácido graso para mejorar uno o más síntomas o condiciones causados por estrés, por ejemplo, pérdida de apetito, o para mantener y mejorar la ingesta de nutrientes y calorías en un animal bajo estrés o que haya experimentado estrés. Generalmente, las alcanolamidas de ácido graso se administran en cantidades de 0.1 a 1500 mg/kg/día antes, durante o después del estrés, preferentemente sobre una base regular o diaria como un componente de una composición alimenticia o como un suplemento dietético.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161575073P | 2011-08-15 | 2011-08-15 | |
PCT/US2012/049825 WO2013025399A1 (en) | 2011-08-15 | 2012-08-07 | Methods for ameliorating symptoms or conditions caused by stress |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2014001767A true MX2014001767A (es) | 2014-05-01 |
Family
ID=47715371
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014001767A MX2014001767A (es) | 2011-08-15 | 2012-08-07 | Metodos para reducir sintomas o condiciones causados por estres. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20140199267A1 (es) |
EP (1) | EP2744488A4 (es) |
JP (1) | JP2014525931A (es) |
CN (1) | CN103917230A (es) |
AU (1) | AU2012295432A1 (es) |
BR (1) | BR112014003445A2 (es) |
CA (1) | CA2846213A1 (es) |
MX (1) | MX2014001767A (es) |
RU (1) | RU2014110056A (es) |
WO (1) | WO2013025399A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2262763A2 (en) | 2008-03-04 | 2010-12-22 | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. | Compounds and methods of treating obesity |
WO2014013497A1 (en) * | 2012-07-20 | 2014-01-23 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Fatty acid derivatives for use in a method of treating depression and associated conditions |
JP6563218B2 (ja) * | 2015-03-13 | 2019-08-21 | ユニ・チャーム株式会社 | ペットフードの製造方法 |
KR101997028B1 (ko) * | 2018-11-30 | 2019-07-05 | 강원대학교산학협력단 | 각성 강화용 유산균 혼합 조성물 및 이의 용도 |
EP4070807A1 (en) * | 2019-12-02 | 2022-10-12 | Life Quality Institute, Inc. | Agent for prevention or remediation of stress disorders and composition containing same |
CN117143760A (zh) * | 2023-07-12 | 2023-12-01 | 西南大学 | 一株能促进5-htp分泌及缓解抑郁的鼠李糖乳酪杆菌ky16及其应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9923738D0 (en) * | 1999-10-07 | 1999-12-08 | Nestle Sa | Nutritional composition |
US20090082435A1 (en) * | 2005-04-28 | 2009-03-26 | The Regents Of The University Of California | Methods, Compositions, And Compounds For Modulation Of Monoacylglycerol Lipase, Pain, And Stress-Related Disorders |
US20070155747A1 (en) * | 2005-12-29 | 2007-07-05 | Kadmus Pharmaceuticals, Inc. | Inhibitors of fatty acid amide hydrolase |
CN101351495A (zh) * | 2005-12-29 | 2009-01-21 | 欧加农股份有限公司 | 脂肪酸酰胺水解酶抑制剂 |
WO2008030752A2 (en) * | 2006-09-07 | 2008-03-13 | N.V. Organon | Methods for determining effective doses of fatty acid amide hydrolase inhibitors in vivo |
JP2011521914A (ja) * | 2008-05-19 | 2011-07-28 | ネステク ソシエテ アノニム | 動物による脂質吸収を抑制する方法 |
US20100190860A1 (en) * | 2009-01-09 | 2010-07-29 | The Brigham And Women's Hospital, Inc. | Methods for selectively enhancing antinociceptive potency of local anesthetics |
-
2012
- 2012-08-07 RU RU2014110056/13A patent/RU2014110056A/ru not_active Application Discontinuation
- 2012-08-07 EP EP12824125.4A patent/EP2744488A4/en not_active Withdrawn
- 2012-08-07 BR BR112014003445A patent/BR112014003445A2/pt not_active IP Right Cessation
- 2012-08-07 US US14/238,237 patent/US20140199267A1/en not_active Abandoned
- 2012-08-07 JP JP2014526067A patent/JP2014525931A/ja not_active Withdrawn
- 2012-08-07 AU AU2012295432A patent/AU2012295432A1/en not_active Abandoned
- 2012-08-07 WO PCT/US2012/049825 patent/WO2013025399A1/en active Application Filing
- 2012-08-07 CA CA2846213A patent/CA2846213A1/en not_active Abandoned
- 2012-08-07 CN CN201280050341.9A patent/CN103917230A/zh active Pending
- 2012-08-07 MX MX2014001767A patent/MX2014001767A/es unknown
Also Published As
Publication number | Publication date |
---|---|
US20140199267A1 (en) | 2014-07-17 |
JP2014525931A (ja) | 2014-10-02 |
CA2846213A1 (en) | 2013-02-21 |
AU2012295432A1 (en) | 2014-02-27 |
BR112014003445A2 (pt) | 2018-03-20 |
CN103917230A (zh) | 2014-07-09 |
EP2744488A1 (en) | 2014-06-25 |
RU2014110056A (ru) | 2015-09-27 |
EP2744488A4 (en) | 2014-07-09 |
WO2013025399A1 (en) | 2013-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2014001767A (es) | Metodos para reducir sintomas o condiciones causados por estres. | |
MX2013002603A (es) | Composicion de aceite y metodo para producir la misma. | |
WO2013153071A3 (en) | A nutritional composition | |
WO2013049519A3 (en) | Compositions, kits and methods for nutritional supplementation with twelve carbon chain fatty acids and twelve carbon chain acylglycerols | |
IN2014CN04115A (es) | ||
MY166016A (en) | Infant nutrition for improving fatty acid composition of brain membranes | |
EA201070419A1 (ru) | Состав для регулирования метаболизма липидов | |
GB201101459D0 (en) | Novel compounds and thier effects on fedding behaviour | |
MX338245B (es) | Metodos y composicioes para inducir la saciedad. | |
MX2015013033A (es) | Metodo para preparar harina de grano entero altamente dispersable con un contenido mejorado de avenantramida. | |
PH12018500035A1 (en) | Nutritional compositions and methods for promoting cognitive development | |
MX2010004642A (es) | Procedimiento para reducir el contenido en acidos grasos saturados de la grasa de leche, productos obtenidos y aplicaciones del mismo. | |
WO2013028555A3 (en) | Methods for weight loss and ketogenic compositions | |
MY166855A (en) | Device For Processing Plant Remnants | |
WO2011092473A8 (en) | Novel compounds and their effects on feeding behaviour | |
MX2011012741A (es) | Un suplemento que comprende grosellas negras o moras grandes. | |
MX344481B (es) | Composiciones nutricionales a base de leche fortificada. | |
MY172574A (en) | Dicaffeoylquinic acid-containing drink | |
MY174494A (en) | Method for inhibiting pathogens using a nutritional composition | |
WO2010119424A3 (fr) | Composition destinee a la regulation du metabolisme des lipides | |
MY169098A (en) | Ready to drink beverages and methods of making thereof | |
WO2012021163A3 (en) | Methods for enhancing the stability of foods, beverages, and cosmetics using natural products derived from non-allergenic proteinaceous sources | |
BR112012016054A2 (pt) | Composições nutricionais compreendendo flocos de fruta incluindo ácido docosa-hexaenoico | |
MX2011007222A (es) | Composicion nutricional para infantes. | |
WO2010072209A3 (de) | Nahrungsergänzungsmittel auf der basis von pantothensäure |